The Mission Fund was set-up by Alex Blyth, a serial entrepreneur and inventor who has experienced first-hand the challenges in securing sufficient funding for new potentially breakthrough cures before they have strong (and thus expensive) proof-of-concept data. Alex is keen to help other potentially curative therapies to get to patients sooner by having access to the right experts and funds to run the their critical experiments to prove their ideas to follow-on investors.

The Mission Fund will create more Unicorn Therapeutic companies over the next decade than any other fund in Europe.